PubMed

Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study.

Kubaszek A, Pihlajamäki J, Komarovski V, Lindi V, Lindström J, Eriksson J, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto J, Uusitupa M, Laakso M; Finnish Diabetes Prevention Study.

Diabetes. 2003 Jul;52(7):1872-6.PMID: 12829659 [PubMed - indexed for MEDLINE]Related articlesFree article

The G-250A promoter polymorphism of the hepatic lipase gene predicts the conversion from impaired glucose tolerance to type 2 diabetes mellitus: the Finnish Diabetes Prevention Study.

Todorova B, Kubaszek A, Pihlajamäki J, Lindström J, Eriksson J, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto J, Uusitupa M, Laakso M; Finnish Diabetes Prevention Study.

J Clin Endocrinol Metab. 2004 May;89(5):2019-23.PMID: 15126514 [PubMed - indexed for MEDLINE]Related articlesFree article

TNF-alpha polymorphisms and type 2 diabetes mellitus in Taiwanese patients.

Shiau MY, Wu CY, Huang CN, Hu SW, Lin SJ, Chang YH.

Tissue Antigens. 2003 May;61(5):393-7.PMID: 12753658 [PubMed - indexed for MEDLINE]Related articles

Interaction of the -308G/A promoter polymorphism of the tumor necrosis factor-alpha gene with single-nucleotide polymorphism 45 of the adiponectin gene: effect on serum adiponectin concentrations in a Spanish population.

González-Sánchez JL, Martínez-Calatrava MJ, Martínez-Larrad MT, Zabena C, Fernández-Pérez C, Laakso M, Serrano-Ríos M.

Clin Chem. 2006 Jan;52(1):97-103. Epub 2005 Oct 27.PMID: 16254197 [PubMed - indexed for MEDLINE]Related articlesFree article

Polymorphisms in the SLC2A2 (GLUT2) gene are associated with the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study.

Laukkanen O, Lindström J, Eriksson J, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto J, Uusitupa M, Laakso M; Finnish Diabetes Prevention Study.

Diabetes. 2005 Jul;54(7):2256-60.PMID: 15983230 [PubMed - indexed for MEDLINE]Related articlesFree article

Common polymorphisms in the genes regulating the early insulin signalling pathway: effects on weight change and the conversion from impaired glucose tolerance to Type 2 diabetes. The Finnish Diabetes Prevention Study.

Laukkanen O, Pihlajamäki J, Lindström J, Eriksson J, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto J, Uusitupa M, Laakso M; Finnish Diabetes Prevention Study Group.

Diabetologia. 2004 May;47(5):871-7. Epub 2004 May 1.PMID: 15127203 [PubMed - indexed for MEDLINE]Related articles

Interaction of single nucleotide polymorphisms in ADRB2, ADRB3, TNF, IL6, IGF1R, LIPC, LEPR, and GHRL with physical activity on the risk of type 2 diabetes mellitus and changes in characteristics of the metabolic syndrome: The Finnish Diabetes Prevention Study.

Kilpeläinen TO, Lakka TA, Laaksonen DE, Mager U, Salopuro T, Kubaszek A, Todorova B, Laukkanen O, Lindström J, Eriksson JG, Hämäläinen H, Aunola S, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto J, Laakso M, Uusitupa M; Finnish Diabetes Prevention Study Group.

Metabolism. 2008 Mar;57(3):428-36.PMID: 18249219 [PubMed - indexed for MEDLINE]Related articles

TNF-alpha, TGF-beta1, IL-10, IL-6, gene polymorphisms in latent autoimmune diabetes of adults (LADA) and type 2 diabetes mellitus.

Tsiavou A, Hatziagelaki E, Chaidaroglou A, Manginas A, Koniavitou K, Degiannis D, Raptis SA.

J Clin Immunol. 2004 Nov;24(6):591-9.PMID: 15622443 [PubMed - indexed for MEDLINE]Related articles

[The correlation between Kawasaki disease and polymorphisms of Tumor necrosis factor alpha and interleukin-10 gene promoter]

Yang J, Li CR, Li YB, Li RX, Sun LB, Huang HJ, Wang GB.

Zhonghua Er Ke Za Zhi. 2003 Aug;41(8):598-602. Chinese. PMID: 14744383 [PubMed - indexed for MEDLINE]Related articles

Cytokine gene polymorphisms in hemodialysis patients: association with comorbidity, functionality, and serum albumin.

Balakrishnan VS, Guo D, Rao M, Jaber BL, Tighiouart H, Freeman RL, Huang C, King AJ, Pereira BJ; HEMO Study Group.

Kidney Int. 2004 Apr;65(4):1449-60.PMID: 15086488 [PubMed - indexed for MEDLINE]Related articles

Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study.

Lindi VI, Uusitupa MI, Lindström J, Louheranta A, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Tuomilehto J; Finnish Diabetes Prevention Study.

Diabetes. 2002 Aug;51(8):2581-6.PMID: 12145174 [PubMed - indexed for MEDLINE]Related articlesFree article

Association of the Leu72Met polymorphism of the ghrelin gene with the risk of Type 2 diabetes in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study.

Mager U, Lindi V, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto J, Laakso M, Pulkkinen L, Uusitupa M; Finnish Diabetes Prevention Study Group.

Diabet Med. 2006 Jun;23(6):685-9.PMID: 16759313 [PubMed - indexed for MEDLINE]Related articles

The common polymorphisms (single nucleotide polymorphism [SNP] +45 and SNP +276) of the adiponectin gene predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.

Zacharova J, Chiasson JL, Laakso M; STOP-NIDDM Study Group.

Diabetes. 2005 Mar;54(3):893-9.PMID: 15734870 [PubMed - indexed for MEDLINE]Related articlesFree article

Genetic variation in leptin receptor gene is associated with type 2 diabetes and body weight: The Finnish Diabetes Prevention Study.

Salopuro T, Pulkkinen L, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto J, Laakso M, Uusitupa M; Finnish Diabetes Prevention Study Group.

Int J Obes (Lond). 2005 Oct;29(10):1245-51.PMID: 15997246 [PubMed - indexed for MEDLINE]Related articles

Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.

Andrulionyte L, Peltola P, Chiasson JL, Laakso M; STOP-NIDDM Study Group.

Diabetes. 2006 Jul;55(7):2148-52.PMID: 16804087 [PubMed - indexed for MEDLINE]Related articlesFree article

Single nucleotide polymorphisms in the interleukin-6 gene promoter, tumor necrosis factor-alpha gene promoter, and transforming growth factor-beta1 gene signal sequence as predictors of time to onset of aseptic loosening after total hip arthroplasty: preliminary study.

Kolundzić R, Orlić D, Trkulja V, Pavelić K, Troselj KG.

J Orthop Sci. 2006 Nov;11(6):592-600. Epub 2006 Dec 4.PMID: 17139467 [PubMed - indexed for MEDLINE]Related articles

Association between interleukin-6 polymorphism and age-at-onset of type 1 diabetes. Epistatic influences of the tumor necrosis factor-alpha and interleukin-1beta polymorphisms.

Hermann C, Krikovszky D, Füst G, Kovács M, Körner A, Szabó A, Vannay A, Madácsy L.

Eur Cytokine Netw. 2005 Dec;16(4):277-81.PMID: 16464741 [PubMed - indexed for MEDLINE]Related articles

Polymorphisms of the SUR1 (ABCC8) and Kir6.2 (KCNJ11) genes predict the conversion from impaired glucose tolerance to type 2 diabetes. The Finnish Diabetes Prevention Study.

Laukkanen O, Pihlajamäki J, Lindström J, Eriksson J, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto J, Uusitupa M, Laakso M; Finnish Diabetes Prevention Study Group.

J Clin Endocrinol Metab. 2004 Dec;89(12):6286-90.PMID: 15579791 [PubMed - indexed for MEDLINE]Related articlesFree article

Interleukin-6 (IL-6) -572C-->G promoter polymorphism is associated with type 2 diabetes risk in Koreans.

Koh SJ, Jang Y, Hyun YJ, Park JY, Song YD, Shin KK, Chae JS, Kim BK, Ordovas JM, Lee JH.

Clin Endocrinol (Oxf). 2009 Feb;70(2):238-44. Epub 2008 Jun 20.PMID: 18573122 [PubMed - indexed for MEDLINE]Related articles

Physical activity modifies the effect of SNPs in the SLC2A2 (GLUT2) and ABCC8 (SUR1) genes on the risk of developing type 2 diabetes.

Kilpeläinen TO, Lakka TA, Laaksonen DE, Laukkanen O, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Aunola S, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto J, Uusitupa M, Laakso M; Finnish Diabetes Prevention Study Group.

Physiol Genomics. 2007 Oct 22;31(2):264-72. Epub 2007 Jul 17. Erratum in: Physiol Genomics. 2008 Feb 19;32(3):419. PMID: 17636114 [PubMed - indexed for MEDLINE]Related articlesFree article